Wockhardt Ltd. successfully used an investigational antibiotic to treat a cancer patient in the US with a chronic infection caused by an extreme-drug resistant Pseudomonas.
AI Assistant
Wockhardt Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.